TrialInternational journal of clinical oncology2020

Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).

Masahito Kotaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.